Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Smith

Showing results (261-270 of 618) with videos related to

Pageof 62
Sort By:
Developmental Cell|September 14, 2010
A zyxin-mediated mechanism for actin stress fiber maintenance and repairMark A Smith, Elizabeth Blankman, Margaret L Gardel, et al.
Journal of Neuroscience Methods|June 29, 2010
Paraffin-embedded tissue (PET) blot method: application to Alzheimer diseaseCalvin F Moh, Sandra L Siedlak, Massimo Tabaton, et al.
Molecular and Cellular Endocrinology|October 21, 2006
Gonadotropins: a cohesive gender-based etiology of Alzheimer diseaseKate M Webber, Gemma Casadesus, Craig S Atwood, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2009
The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptorsMark A Smith, Jennifer L Greene-Naples, Megan A Lyle, et al.
Developmental Neuroscience|October 29, 2002
Iron: a pathological mediator of Alzheimer disease?Glenda M Bishop, Stephen R Robinson, Quan Liu, et al.
Advances in Experimental Medicine and Biology|March 14, 2012
Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseasesSónia C Correia, Renato X Santos, George Perry, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2017
Long noncoding miRNA gene represses wheat β-diketone waxesDaiqing Huang, J Allan Feurtado, Mark A Smith, et al.
Journal of Clinical Psychopharmacology|February 15, 2014
The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle studyRobert E Litman, Mark A Smith, Dhaval G Desai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2008
Current approaches in the treatment of Alzheimer's diseaseReena S Shah, Hyoung-Gon Lee, Zhu Xiongwei, et al.
Results and Problems in Cell Differentiation|June 2, 2011
Cell cycle deregulation in the neurons of Alzheimer's diseaseCalvin Moh, Jacek Z Kubiak, Vladan P Bajic, et al.
Pageof 62

Showing results (261-270 of 618) with videos related to

Sort By:
Pageof 62
Developmental Cell|September 14, 2010
A zyxin-mediated mechanism for actin stress fiber maintenance and repairMark A Smith, Elizabeth Blankman, Margaret L Gardel, et al.
Journal of Neuroscience Methods|June 29, 2010
Paraffin-embedded tissue (PET) blot method: application to Alzheimer diseaseCalvin F Moh, Sandra L Siedlak, Massimo Tabaton, et al.
Molecular and Cellular Endocrinology|October 21, 2006
Gonadotropins: a cohesive gender-based etiology of Alzheimer diseaseKate M Webber, Gemma Casadesus, Craig S Atwood, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2009
The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptorsMark A Smith, Jennifer L Greene-Naples, Megan A Lyle, et al.
Developmental Neuroscience|October 29, 2002
Iron: a pathological mediator of Alzheimer disease?Glenda M Bishop, Stephen R Robinson, Quan Liu, et al.
Advances in Experimental Medicine and Biology|March 14, 2012
Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseasesSónia C Correia, Renato X Santos, George Perry, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2017
Long noncoding miRNA gene represses wheat β-diketone waxesDaiqing Huang, J Allan Feurtado, Mark A Smith, et al.
Journal of Clinical Psychopharmacology|February 15, 2014
The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle studyRobert E Litman, Mark A Smith, Dhaval G Desai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2008
Current approaches in the treatment of Alzheimer's diseaseReena S Shah, Hyoung-Gon Lee, Zhu Xiongwei, et al.
Results and Problems in Cell Differentiation|June 2, 2011
Cell cycle deregulation in the neurons of Alzheimer's diseaseCalvin Moh, Jacek Z Kubiak, Vladan P Bajic, et al.
Pageof 62